Silver Book Fact

Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.

Gunther, Weigert, Semira Kaya, Berthold Pemp, Stefan Sacu, Michael Lasta, Rene Marcel Werkmeister, Nikolaus Dragostinoff, Christian Simader, Gerhard Garhofer, Ursula Schmidt-Erfurth, and Leopold Shcmetterer. Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. October 2011; 52(11): 8174-8. http://www.iovs.org/content/52/11/8174.abstract

Reference

Title
Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration
Publication
Invest Ophthalmol Vis Sci
Publication Date
October 2011
Authors
Gunther, Weigert, Semira Kaya, Berthold Pemp, Stefan Sacu, Michael Lasta, Rene Marcel Werkmeister, Nikolaus Dragostinoff, Christian Simader, Gerhard Garhofer, Ursula Schmidt-Erfurth, and Leopold Shcmetterer
Volume & Issue
Volume 52, Issue 11
Pages
8174-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Women taking vitamins B6 and B12 and folic acid–as compared to women not taking these supplements–were found to have a 34% lower risk of age-related macular degeneration (AMD) and a…  
  • Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.  
  • Omega-3 polyunsaturated fatty acids have been found to protect against the development and progression of deterioration of the retina (retinopathy).  
  • A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43%…  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.